Deal Announcements

NABsys Nabs Series C Venture Capital Investment

Thursday, September 15, 2011 5:54:00 AM PDT | VentureDeal Staff

Providence, Rhode Island  --  Biotechnology company NABsys has landed $10 million in its third round of venture capital funding, according to a company statement.

NABsys has developed whole-genome sequencing technology that it says is "fast, inexpensive and accurate enough to be used in clinical care."

Stata Venture Partners led the round. The company said it would use the financing to support the continued development of its technology.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1